Siamo entusiasti di annunciare un importante traguardo nel nostro progetto Teracor! Alla rendicontazione dello Stato di Avanzamento Lavori (SAL) del progetto co-finanziato da Lazio Innova con fondi Europei abbiamo completato oltre il 60% degli obiettivi ...
🔬 Breakthrough Advancement in Clinical Research for the Treatment of Keratoconus 🔬 We are excited to announce the publication of the ARGO clinical trial validating theranostics technology for the precision, predictive and personalized treatment of ke ...
Regensight will join the most important and awaited International Annual Conference in corneal and cataract surgery organized by ESCRS in Barcelona (https://congress.escrs.org/) on 6-10 September 2024. With validation of theranostics in the randomized mu ...
We are excited to announce the publication of a new scientific article, entitled "Spatial targeted delivery of riboflavin with a controlled corneal iontophoresis delivery system in theranostic-guided UV-A light photo-therapy", in the prestigious Journal ...
Glad to share the outcomes of a recent manuscript, published on Graefe’s Archive for Clinical & Experimental Ophthalmology, assessing the performance of several clinically available riboflavin ophthalmic formulations for corneal cross-linking. The ...
The project n. A0613-2023-077528 of Regensight srl was granted by Lazio Innova in response to the "RSI Competitive Repositioning" Public Notice, FESR Program 2021-2027 referred to in Det. n. G18823 dated 12/28/2022 and granted with the Det. n. G15206 date ...
The Regensight's Theranostics (a new paradigm of therapy guided by diagnostics), is going to halt keratoconus progression with certainty. Keratoconus is primary cause of corneal transplant in young adults worldwide (prevalence: 1% - 2%, about 100 mil ...
The Regensight team has been an active part of The European Society of Cataract and Refractive Surgery (ESCRS) International Conference, which was held in Vienna from 8 to 11 September 2023.At the startup's stand, the Team has allowed the eye surgeons to ...
Visit us at our booth C405 (Hall C) on 8 - 11 September during ESCRS 2023 and meet our Team! We at Regensight are introducing Theranostics for incision-free treatment of visual disorders. You will discover the C4V CHROMO4VIS breakthrough UV-A devic ...
In a recent study published in the prestigious Journal of Cataract & Refractive Surgery, theranostic-guided corneal cross-linking has been confirmed to induce precise and predictive corneal tissue strengthening in eye-bank human donor tissues through ...
